ondansetron has been researched along with Visceral Pain in 1 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
Visceral Pain: Pain originating from internal organs (VISCERA) associated with autonomic phenomena (PALLOR; SWEATING; NAUSEA; and VOMITING). It often becomes a REFERRED PAIN.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hall, JD | 1 |
| DeWitte, C | 1 |
| Ness, TJ | 1 |
| Robbins, MT | 1 |
1 other study available for ondansetron and Visceral Pain
| Article | Year |
|---|---|
Serotonin enhances urinary bladder nociceptive processing via a 5-HT3 receptor mechanism.
Topics: 5-Hydroxytryptophan; Animals; Female; Nociception; Ondansetron; Pain Measurement; Rats, Inbred Lew; | 2015 |